A Chinese medicinal compound composition capable of delaying kidney aging and fibrosis, and its preparation method and application

The traditional Chinese medicine compound composition made of astragalus, hollyhock, Centella asiatica, Salvia miltiorrhiza, licorice and Cordyceps mycelium were prepared in a variety of dosage forms in combination with pharmaceutical carriers, which solved the problems of kidney aging and fibrosis, significantly delayed the symptoms of aging and restored the symptoms of aging and restored. Kidney function has safe and effective longevity effect.

CN117599105BActive Publication Date: 2024-11-05JIANGSU PROVINCIAL HOSPITAL OF TCM
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202311543505.8
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2023-11-20
Publication Date
2024-11-05
Estimated Expiration
2043-11-20

AI Technical Summary

Technical Problem

The prior art is difficult to effectively delay renal aging and fibrosis, and there is a lack of effective Chinese medicine compound compositions to inhibit KAT7 levels to resist aging and prolong life.

Method used

The Chinese medicine compound composition made of astragalus, hollyhock, Centella asiatica, Salvia miltiorrhiza, licorice and Cordyceps mycelium were extracted by soaking, decoction, filtration and rotary evaporation, and combined with pharmaceutical carriers to prepare a variety of extracts. Dosage form, used to nourish kidney qi, benefit kidney essence, activate qi and blood, clear dampness, and delay kidney aging and fibrosis.

Benefits of technology

It significantly delays renal aging and fibrosis, restores renal function, reduces symptoms of aging and fibrosis, has the effects of anti-natural aging and prolongs life, and is safe in clinical use, reliable in efficacy, and has no long-term toxic side effects.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN117599105B_ABST
    Figure CN117599105B_ABST
Patent Text Reader

Abstract

The invention discloses a Chinese medicine compound composition with the function of delaying kidney aging and fibrosis and a preparation method thereof. The Chinese medicine compound composition is prepared from an extract obtained from 240-480g of Astragalus, 240-480g of Hibiscus hibiscus flower, 240-480g of Centella asiatica, 120-240g of Salvia miltiorrhiza, and 40-80g of Licorice and Cordyceps mycelium. The invention screens a prescription through many years of clinical experience, combined with the pathogenesis of kidney aging, and adds two medicines, Centella asiatica and Cordyceps mycelium, on the basis of Astragalus, Hibiscus hibiscus flower, Salvia miltiorrhiza, and Licorice, which can significantly enhance the effects of clearing, promoting blood circulation, and invigorating qi and tonifying the kidney. The medicines in the prescription are harmonized, and by invigorating kidney qi, invigorating kidney essence, invigorating qi and blood, clearing dampness and turbidity, combined with the treatment concept of protecting the kidney and delaying aging, it becomes a commonly used prescription for kidney function decline and early kidney damage in clinical practice. The experimental results show that the Chinese medicine compound of the present invention can restore kidney function. SA, HE and Masson staining of the kidney show that the symptoms of aging and fibrosis are alleviated after Chinese medicine treatment, and it has good anti-natural aging and longevity effects.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to a Chinese medicine composition, in particular to a Chinese medicine compound composition capable of delaying kidney aging and fibrosis and a preparation method thereof, belonging to the technical field of traditional Chinese medicine. Background Art

[0002] In traditional Chinese medicine, it is believed that the kidneys contain innate and acquired essence. The earliest mention of this in the Suwen · Six Sections on Zang Xiang is that "the kidneys are the master of hibernation, the root of storage, and the place of essence." The Suwen · Jinkui Zhenlun believes that essence is the root of life. Innate essence is inherited from parents, while acquired essence is formed after food is taken into the body, decomposed by the stomach, transformed by the intestines and spleen, and condensed. The kidneys are responsible for storing essence to nourish the five internal organs, so the ability of the kidneys to store essence and the movement of essence, qi, and water that they dominate will inevitably affect the health of the whole body. Ancient doctors pointed out that when the kidneys age, the qi transformation is abnormal, dampness, turbidity, blood stasis and toxins block the triple energizer, "kidney collaterals" are formed, and eventually a variety of diseases occur.

[0003] Kidneys are one of the most vulnerable organs to aging due to their physiological functions, which are responsible for regulating the body's fluid metabolism. With age, kidney structure and function become lesions, and kidney fibrosis occurs, further promoting the decline of kidney function. Studies have also shown that kidneys with chronic kidney disease have similar characteristics to aging kidneys.

[0004] The Institute of Zoology of the Chinese Academy of Sciences systematically studied aging genes through whole genome gene editing technology and found that the expression difference of KAT7 was most obvious in the aging of primary bone marrow mesenchymal stem cells (hMPCs) of patients with progeria. KAT7 can promote the expression of aging marker genes and induce cell senescence by selectively acetylating histone H3K14. Studies on animal models of natural aging have found that inactivation of KAT7 can make 81% of mice live more than 130 weeks, while only 27% of mice in the control group can live to 130 weeks. With the proposed role of KAT7 in aging, explorations on the correlation between KAT7 and aging of different organs have gradually emerged in recent years, suggesting the research value of KAT7 in different species, multiple organs, and different aging-related diseases. This suggests that inhibiting KAT7 levels may have important research value in resisting aging and prolonging life.

[0005] Traditional Chinese medicine has unique advantages in anti-aging and prolonging life. Therefore, under the guidance of traditional Chinese medicine theory and combined with clinical practice, the present invention selects a traditional Chinese medicine compound composition that can significantly delay kidney aging and renal fibrosis. Summary of the invention

[0006] Purpose of the invention: The purpose of the present invention is to solve the deficiencies of the prior art, adopt the theory of "protecting the kidney and delaying aging", and optimize the Chinese medicine compound composition that can effectively delay kidney aging and fibrosis by replenishing kidney qi, benefiting kidney essence, activating qi and blood, clearing dampness and turbidity, and treating according to syndrome differentiation. Another purpose of the present invention is to provide a preparation method and application of the Chinese medicine compound composition.

[0007] Technical solution: In order to achieve the above purpose, the technical solution adopted by the present invention is:

[0008] A Chinese medicinal compound composition having the function of delaying kidney aging and fibrosis, which is prepared from the following raw materials:

[0009] Astragalus, Hibiscus tiliaceus flower, Centella asiatica, Salvia miltiorrhiza, Licorice root and Cordyceps mycelium.

[0010] As a preferred embodiment, the above-mentioned Chinese medicinal compound composition for delaying kidney aging and fibrosis is made of extracts made from astragalus, hibiscus flower, Centella asiatica, salvia miltiorrhiza, and liquorice, and Cordyceps mycelium.

[0011] As a further preferred embodiment, the above-mentioned Chinese herbal compound composition for delaying kidney aging and fibrosis is made of extracts made from 240-480g of Astragalus, 240-480g of Abelmoschus flower, 240-480g of Centella asiatica, 120-240g of Salvia miltiorrhiza, and 40-80g of Licorice, and Cordyceps mycelium.

[0012] As a particularly preferred embodiment, the above-mentioned Chinese herbal compound composition for delaying kidney aging and fibrosis is made of extracts made from 240g of Astragalus, 240g of Hibiscus hibiscus flower, 240g of Centella asiatica, 120g of Salvia miltiorrhiza, and 40g of Licorice, and Cordyceps mycelium.

[0013] As a further preferred embodiment, in the above-mentioned Chinese herbal compound composition for delaying kidney aging and fibrosis, the weight ratio of the extract of the Chinese herbal compound to the Cordyceps mycelium is 1:0.88-1.

[0014] The Chinese medicinal compound composition for delaying kidney aging and fibrosis of the present invention is prepared by the following method:

[0015] Take astragalus, hibiscus flower, Centella asiatica, salvia miltiorrhiza and liquorice, add water to submerge the medicinal materials, soak them first, then decoct and extract them, use gauze to squeeze the residue to collect the decoction, add water to the residue and decoct them again, collect the decoctions twice, filter them with gauze, concentrate the filtrate by rotary evaporation, pre-freeze and use a vacuum freeze dryer to obtain freeze-dried powder.

[0016] As a preferred embodiment, the above-mentioned Chinese medicine compound composition for delaying kidney aging and fibrosis, the extract is prepared by the following method:

[0017] Take astragalus, hibiscus flower, Centella asiatica, salvia miltiorrhiza and liquorice, add 5 to 15 times the volume of water by weight of the medicinal materials to immerse the medicinal materials, soak for 30 to 40 minutes, decoct and extract for 30 to 60 minutes, squeeze the residue with gauze to collect the decoction, add 5 to 15 times the volume of water to the residue again and decoct for 30 to 60 minutes, collect the decoctions twice, filter with gauze, concentrate the filtrate by rotary evaporation, pre-freeze at -80°C for 24 hours, and then use a vacuum freeze dryer for 72 hours to obtain a freeze-dried powder.

[0018] A Chinese medicine compound composition and a pharmaceutically acceptable carrier are prepared into granules, tablets, capsules, pills, oral liquids, powders, mixtures and pastes.

[0019] When preparing tablets, the traditional Chinese medicine extract is added with carrier lactose or corn starch, and lubricant magnesium stearate is added when necessary, mixed evenly, and then compressed into tablets.

[0020] When preparing the capsule, the Chinese medicine extract is mixed evenly with dextrin or starch, granulated, and then filled into capsules to prepare the capsule.

[0021] When preparing the granules, the Chinese medicine extract is mixed with dextrin and the like, granulated, and dried to prepare the granules.

[0022] When preparing the mixture, the Chinese medicine extract is dissolved in purified water to prepare the mixture.

[0023] When preparing the oral liquid, the traditional Chinese medicine extract is dissolved in purified water, stevioside or aspartame is added, and the pH is adjusted to prepare the oral liquid.

[0024] Beneficial effects: Compared with the prior art, the present invention has the following advantages:

[0025] (1) The present invention has screened the prescription based on many years of clinical experience and combined with the pathogenesis of kidney aging. On the basis of Astragalus, Radix Astragali, Radix Salviae Miltiorrhizae and Radix Glycyrrhizae, two herbs, Centella asiatica and Cordyceps mycelium, are added, which can significantly enhance the effects of clearing and promoting blood circulation, invigorating qi and tonifying the kidney. The various herbs in the prescription are harmonized, and by tonifying kidney qi, invigorating kidney essence, invigorating qi and blood, clearing dampness and turbidity, combined with the treatment concept of protecting the kidney and delaying aging, it has become a commonly used prescription for kidney function decline and early kidney damage in the clinic. The experimental results show that the Chinese medicine compound provided by the present invention can restore kidney function, and kidney SA, HE and Masson staining show that the symptoms of aging and fibrosis are alleviated after Chinese medicine treatment. It has a good effect of resisting natural aging and prolonging life.

[0026] (2) The Chinese medicine compound composition for delaying kidney aging and resisting renal fibrosis provided by the present invention can be conveniently prepared into a variety of dosage forms with pharmaceutical carriers, and is convenient to take clinically. Experimental results show that the composition provided by the present invention has reliable efficacy, is safe to use, and has no toxic side effects when taken for a long time. BRIEF DESCRIPTION OF THE DRAWINGS

[0027] Figure 1 Traditional Chinese medicine regulates KAT7 to alleviate renal aging and fibrosis in mice (bar: 100μm).

[0028] Figure 2 Traditional Chinese medicine regulates KAT7 to improve the expression of proteins related to renal aging and fibrosis in mice. ※Note: * represents comparison with the blank group, # represents comparison with the previous group; *P, #P<0.05, **P, ##P<0.01, ***P, ###P<0.001, ****P, ####P<0.001.

[0029] Figure 3 The Chinese medicine serum regulates KAT7 to reduce the senescence and fibrosis of renal tubular epithelial cells (100×). ※Note: * represents the comparison with the blank group, # represents the comparison with the previous group; *P, #P<0.05, **P, ##P<0.01, ***P, ###P<0.001, ****P, ####P<0.001. DETAILED DESCRIPTION

[0030] The present invention can be better understood according to the following examples. However, it is easy for those skilled in the art to understand that the specific material ratios, process conditions and results described in the examples are only used to illustrate the present invention, and should not and will not limit the present invention described in detail in the claims.

[0031] Example 1

[0032] 1. A Chinese medicinal compound composition for delaying kidney aging and fibrosis, which is made from the following raw materials in parts by weight:

[0033] The weight ratio of the Chinese medicine compound extract to the cordyceps mycelium is 1:0.88.

[0034] The extract of the Chinese medicinal compound is prepared by the following method:

[0035] Take 240g of Astragalus, 240g of Hibiscus hibiscus, 240g of Centella asiatica, 120g of Salvia miltiorrhiza, and 40g of Licorice, add water to submerge the medicinal materials and soak for 30 minutes, add 5L of pure water, boil over high heat and then simmer for 30 minutes, squeeze the residue with gauze to collect the decoction, add 5L of pure water again and boil for 30 minutes; collect the decoction twice and filter it with 8 layers of gauze. After rotary evaporation and concentration to about 400mL, divide it into 50mL EP tubes (15-20mL per tube), pre-freeze at -80℃ for 24h, and then use a vacuum freeze dryer for 72h to obtain freeze-dried powder.

[0036] The freeze-dried powder is mixed with Cordyceps mycelium powder in a mass ratio of 1:0.88 to obtain a compound freeze-dried mixed powder. When used, take the compound freeze-dried mixed powder, add an appropriate amount of ultrapure water, and add 0.5% sodium carboxymethyl cellulose, stir evenly, and use it immediately after preparation.

[0037] Example 2

[0038] 1. A Chinese medicinal compound composition for delaying kidney aging and fibrosis, which is made from the following raw materials in parts by weight:

[0039] The weight ratio of the Chinese herbal compound extract to the cordyceps mycelium is 1:1.

[0040] The method for preparing the extract of the Chinese medicinal compound is the same as that in Example 1.

[0041] Example 3

[0042] 1. A Chinese medicinal compound composition for delaying kidney aging and fibrosis, which is made from the following raw materials in parts by weight:

[0043] The weight ratio of the Chinese medicine compound extract to the cordyceps mycelium is 1:0.88.

[0044] The extract of the Chinese medicinal compound is prepared by the following method:

[0045] Take 480g of Astragalus, 480g of Hibiscus hibiscus, 480g of Centella asiatica, 240g of Salvia miltiorrhiza, and 80g of Licorice, add water to submerge the medicinal materials and soak for 30 minutes, add 10L of pure water, boil over high heat and then simmer for 40 minutes, squeeze the residue with gauze to collect the decoction, add 10L of pure water again and boil for 30 minutes; collect the decoction twice and filter it with 8 layers of gauze. After rotary evaporation and concentration to about 800mL, divide it into 50mL EP tubes (15-20mL per tube), pre-freeze at -80℃ for 24h, and then use a vacuum freeze dryer for 72h to obtain freeze-dried powder.

[0046] The freeze-dried powder was mixed with Cordyceps mycelium powder in a mass ratio of 1:0.88 to obtain a compound freeze-dried mixed powder.

[0047] When using, take the compound freeze-dried powder mixture, add appropriate amount of ultrapure water, and add 0.5% sodium carboxymethyl cellulose, stir evenly, and use it immediately after preparation.

[0048] Example 4: Drug efficacy test for delaying renal aging and fibrosis

[0049] 1. Improve kidney aging in naturally aged mice

[0050] 1.1 Experimental Materials

[0051] 1.1.1 Experimental reagents

[0052]

[0053]

[0054] 1.1.2 Experimental instruments

[0055] Main instruments model factory Inverted fluorescence microscope Axio Vert A1 ZEISS Multifunctional ELISA reader PE PerkinElmer Gel imaging system LAS 4000 FUJIFILM Western blot gel electrophoresis equipment MiNi ROTEAN Bio-rad Ultra-low temperature refrigerator UUS-410D-SS ESCO Water Purifier Milli-Q Integral 15 MERCK Clean bench ACB-4A1 ESCO CO2 Cell Culture Incubator HERAcell 150i Thermo Cell Counter C 10227 Thermo .

[0056] 1.1.3 Experimental animals

[0057] SPF-grade C57BL / 6 female mice were selected as experimental animals. Among them, 8 2-month-old mice and 24 6-month-old mice were purchased from Jiangsu Huachuang Xinnuo Biotechnology Co., Ltd., with animal license number SCXK (Su) 2020-0009. They were raised in the SPF environment of the Animal Experiment Center of Nanjing University of Chinese Medicine, with a 12-hour light / dark cycle, a temperature of 22±3°C, and a humidity of 50±10%. Mice were given maintenance feed and sufficient clean drinking water. 30 7-10-day-old C57BL / 6 suckling mice were purchased from Jiangsu Huachuang Xinnuo Biotechnology Co., Ltd., with animal license number SCXK (Su) 2020-0009. The ethics of animal experiments were approved by the Animal Experiment Center of Nanjing University of Chinese Medicine, with approval number: 202108A006.

[0058] 1.1.4 Preparation of experimental reagents

[0059] The Chinese medicinal materials and pieces used in the experiment were provided by the Preparation Department of Jiangsu Provincial Hospital of Traditional Chinese Medicine. Preparation of Chinese medicine compound samples: Take 240g of Astragalus, 240g of Hibiscus hibiscus, 240g of Centella asiatica, 120g of Salvia miltiorrhiza, and 40g of Licorice, add water to submerge the medicinal materials and soak for 30min, make up to 5L of pure water, boil over high heat and then simmer for 30min, squeeze the residue with gauze to collect the decoction, add 5L of pure water to decoct again; collect the decoction twice and filter it with 8 layers of gauze. After rotary evaporation and concentration to about 400mL, divide it into 50mL EP tubes (15-20mL per tube), pre-freeze at -80℃ for 24h, and then use a vacuum freeze dryer for 72h to obtain 160g of freeze-dried powder, with a yield of 18.2%. The freeze-dried powder was mixed with Cordyceps mycelium powder in a ratio of 1:0.88 to obtain a compound freeze-dried mixed powder. When using, take the compound freeze-dried powder mixture, add appropriate amount of ultrapure water, and add 0.5% sodium carboxymethyl cellulose, stir evenly, and use it immediately after preparation.

[0060] D-gal animal medication: Weigh 5g of D-gal, add 100mL of sterile water, mix well to obtain a D-gal injection solution with a concentration of 500mg / mL, and store at 4℃.

[0061] Electrophoresis buffer: Weigh 30.2 g of Tris, 144 g of Glycine, and 10 g of SDS, add ddH2O, stir evenly, and dilute to 1000 mL to obtain 10× electrophoresis stock solution. Take 200 mL of the stock solution, add ddH2O and dilute to 2000 mL to obtain 1× electrophoresis buffer.

[0062] Transfer buffer: Take 50 mL of 20× rapid transfer buffer, add 100 mL of anhydrous ethanol, and add ddH2O to make the volume to 1000 mL to obtain 1× rapid transfer buffer.

[0063] TBS / TBST buffer: Weigh 80 g of NaCl and 24.4 g of Tris respectively, add H2O and stir evenly, dilute to 1000 mL to obtain 10×TBS buffer. Take 200 mL of 10× buffer, add H2O, and add 2 mL of Tween 20 and stir, dilute to 2000 mL with ddH2O to obtain 1×TBST buffer.

[0064] 1.2 Experimental methods

[0065] 1.2.1 Animal intervention

[0066] After one week of adaptive feeding, 6-month-old mice were given sufficient maintenance feed and clean drinking water, and continued to be raised until 16 months of age. They were randomly divided into 3 groups: Aging group, low-dose Chinese medicine compound group (HY-L group), and high-dose Chinese medicine compound group (HY-H group), with 8 mice in each group. They were gavaged with 0.2mL / 20g / d of normal saline, 2g / kg / d of freeze-dried mixed powder, and 4g / kg / d of freeze-dried mixed powder, respectively, and the administration was continued for 60 days. Six 2-month-old mice were raised to 4 months of age as the young control group, during which they were gavaged with 0.2mL / 20g / d of normal saline. After the intervention in each group, the mice were killed, and blood, urine, and kidney tissue were collected for detection.

[0067] 1.2.2 Protein expression in kidney tissue

[0068] Western blot was used to detect the expression of aging-related proteins P21, P16, LaminB1, and γH2Ax; the expression of fibrosis-related proteins COLⅠ and α-SMA; the expression of KAT7 and inflammasome-related proteins NLRP3 and IL-1β.

[0069] The specific operation of Western blot of kidney tissue is as follows: cut 50mg of kidney cortex with ophthalmic scissors, peel off the kidney capsule, wash with PBS, absorb excess water with filter paper, cut into pieces and put into 2mL EP tube, add 500μL of mixed protein lysis solution (RIPA: protease inhibitor mixture = 100:1), add two 3mm steel beads, and use a low-temperature homogenizer to homogenize twice at 30 power, 4℃, and 3min. After removing the steel beads, ultrasonicate at 50% power for 8s + cool on ice for 8s, and repeat ultrasonication 5 times. Centrifuge at 12000rpm, 4℃, and 15min, and take 5μL of supernatant for protein concentration determination. Add 1 / 4 volume of 5× protein loading buffer to the remaining supernatant, vortex mix, denature at 99℃ for 10min in a metal bath, cool and package, and store at -80℃ for use.

[0070] Use the gel making kit to prepare the gel of appropriate concentration, load the sample according to the protein concentration determination result, perform electrophoresis at a constant voltage of 160V, use the fast transfer solution to transfer the membrane at a current of 400mA, and transfer the membrane for 10-50min depending on the molecular weight of the target protein. Block with the fast blocking solution for 15min, wash with TBST for 3min×3 times, and incubate the membrane in the corresponding primary antibody at 4℃ overnight. The next day, take out the membrane and wash it with TBST for 5min×2 times + 10min×2 times. Put the membrane in the corresponding species secondary antibody, incubate at room temperature for 1 hour, wash with TBST for 5min×2 times + 10min×2 times, and add ECL chemical developer for exposure. Each experiment was repeated 3 times independently, and grayscale values ​​were calculated using Image J, and statistics and graphs were made using Graph Pad Prism.

[0071] 1.2.3 Renal function test

[0072] After the blood was collected from the mice, it was placed on ice for 4 hours, centrifuged at 4°C and 3000rpm for 15 minutes, and the serum was aspirated and stored at -80°C. The mouse urine was collected by bladder compression and stored at -80°C. The levels of blood creatinine, blood urea nitrogen, blood uric acid, and urine protein in mice were detected using a biochemical kit. The working solution was added according to the instructions, and the sample, standard, and distilled water were added respectively. After incubation, the absorbance was detected in an ELISA instrument, and the concentration of the target protein in the sample was calculated using Office Excel according to the algorithm in the instructions, and Graph Pad Prism was used for statistics and graphing.

[0073] 1.2.4 Kidney SA-β-gal staining

[0074] The kidney tissue was embedded in OTC and frozen sections were made. The sections were washed with PBS for 5 min × 3 times, and the fixative was added to cover the surface. The sections were fixed at room temperature for 20 min, and the fixative was discarded and washed with PBS for 5 min × 3 times. The staining working solution was prepared according to the ratio of components A: B: C: X = 1: 1: 93: 5. 500 μL of working solution was added to each section, and it was placed in a moisturizing dark box and baked in a 37 ° C oven overnight. The next day, the working solution was discarded, 0.1% nuclear fast red stain was added for 20 min, and PBS was used to wash for 5 min × 3 times. The sections were sealed with glycerol gelatin sealing solution, and the blue positive area was observed under an optical microscope.

[0075] 1.2.5 Renal histopathological staining

[0076] Paraffin sections were made and stained with HE, Masson and Sirius red.

[0077] The specific steps of Sirius red staining are as follows: bake the kidney tissue slices in a 70℃ oven for 40 minutes, and use xylene I, xylene II, and gradient alcohol for hydration treatment in sequence. Soak in saturated Sirius red staining solution for 1 hour, rinse with running water for 10 seconds, soak in 0.5% acetic acid solution for 20 seconds, rinse with running water, dehydrate with gradient ethanol and xylene, seal with neutral gum, and observe and photograph with a polarized light microscope after drying.

[0078] 1.2.6 Immunofluorescence staining of kidney tissue

[0079] The kidney tissue sections were baked in a 70℃ oven for 40min, and then hydrated with xylene I, xylene II, and gradient alcohol. Antigen retrieval solution was used to repair at 95℃ for 10min, and then washed with PBS for 5min×3 times after cooling. 5% goat serum was added for blocking for 30min, the serum was shaken off, the tissue was circled with a histochemical pen, and a 1:100 diluted Lamin B1 rabbit primary antibody was added, and the sections were moisturized in a dark box at 4℃ for 8h. The next day, the sections were taken out and rewarmed for 15min, and the Antibody wash buffer was used to shake for 5min×3 times, and then washed with PBS for 3min. Then a 1:100 diluted KAT7 mouse anti-antibody was added and incubated for 8h, and the shaking and washing operation was repeated. A 1:100 ratio of red fluorescent rabbit secondary antibody and green fluorescent mouse secondary antibody were added, and incubated at room temperature in the dark for 1h. The same shaking and washing operation as the primary antibody was performed. DAPI was added to stain the cell nucleus for 15min, and PBS was shaken for 3min×3 times. The sections were sealed with antifade sealing solution, and the red, green, and blue fluorescence were observed and photographed.

[0080] 1.2.7 Data Processing

[0081] Image J was used to detect protein grayscale values ​​and process images. Image pro plus was used to count pathological staining. Prism GraphPad 8.0 was used to analyze statistical data and make quantitative graphs. ANOVA one-way analysis of variance was used to express differences between groups, LSD method was used to express differences between two groups, and It represents quantitative data, and P < 0.05 indicates that the difference is statistically significant.

[0082] 2. Improve the senescence of primary mouse renal tubular epithelial cells

[0083] 2.1 Experimental Materials

[0084] 2.1.1 Experimental reagents and instruments

[0085] Same as 1.1.1 and 1.1.2 above.

[0086] 2.1.2 Experimental animals

[0087] Twenty SPF male SD rats, weighing about 250 g, were purchased from Jiangsu Huachuang Xinnuo Biotechnology Co., Ltd., animal license number SCXK (Su) 2020-0009. They were kept in the SPF environment of the Animal Experiment Center of Nanjing University of Chinese Medicine, with a 12-h light / dark cycle, a temperature of 22±3°C, and a humidity of 50±10%. Rats were given maintenance feed and sufficient clean drinking water.

[0088] 2.1.3 Preparation of experimental reagents

[0089] The tested Chinese herbal compound is the same as that in 1.1.3 above. When using, take the compound freeze-dried powder mixture, add appropriate amount of ultrapure water, and add 0.5% sodium carboxymethyl cellulose, stir evenly, and use it immediately after preparation.

[0090] D-gal cell administration: Weigh 4.504 g D-gal, add 50 mL sterile water, mix well to obtain a 500 mM D-gal stock solution, filter through a 0.22 μm filter head and dispense into 1.5 mL EP tubes, seal and store at -20°C.

[0091] Electrophoresis buffer: Weigh 30.2 g of Tris, 144 g of Glycine, and 10 g of SDS, add ddH2O, stir evenly, and dilute to 1000 mL to obtain 10× electrophoresis stock solution. Take 200 mL of the stock solution, add ddH2O and dilute to 2000 mL to obtain 1× electrophoresis buffer.

[0092] Transfer buffer: Take 50 mL of 20× rapid transfer buffer, add 100 mL of anhydrous ethanol, and add ddH2O to make the volume to 1000 mL to obtain 1× rapid transfer buffer.

[0093] TBS / TBST buffer: Weigh 80 g of NaCl and 24.4 g of Tris respectively, add H2O and stir evenly, dilute to 1000 mL to obtain 10×TBS buffer. Take 200 mL of 10× buffer, add H2O, and add 2 mL of Tween 20 and stir, dilute to 2000 mL with ddH2O to obtain 1×TBST buffer.

[0094] 2.2 Experimental methods

[0095] 2.2.1 Preparation of drug-containing serum

[0096] After 3 days of adaptive feeding, the rats were randomly divided into 2 groups, including 5 in the blank group, which were given 2mL / 250g / d of normal saline by gavage. The Chinese medicine group had 15 rats, and they were given Chinese medicine freeze-dried mixed powder solution by gavage once in the morning and evening every day, with a dose of 1.1g / kg. After 4 days of gavage, serum was obtained by anesthesia. The specific operation was as follows: after sufficient anesthesia by injection of sodium pentobarbital, the abdominal cavity was opened and the viscera were pushed away, the connective tissue was bluntly separated with cotton balls, the abdominal aorta was exposed, and the blood was collected using a disposable blood collection needle and a vacuum blood collection tube. After the collection was completed, the rats were killed. The blood collection tube was placed on ice for 2h and then centrifuged at 3000r for 15min at 4℃. The supernatant was aspirated into a 50mL EP tube and placed in a 56° water bath for endotoxin inactivation for 30min. Transferred to the clean bench and filtered with a 0.22μm filter head, divided into 1.5mL tubes, and stored at -80℃.

[0097] 2.2.2 Primary cell extraction and intervention

[0098] Primary cell extraction and culture method: Materials collection: The suckling mice were killed and soaked in 75% alcohol for full disinfection. The kidneys were quickly removed from the back, washed in PBS to remove the capsule and medulla, and transferred into Hanks buffer and cut into pieces of about 1mm3. Transferred into a 15mL tube and supplemented with 5mL Hanks buffer, centrifuged at 1500rpm for 5min. The supernatant was discarded, 3mL 0.1% collagenase IV was added, and the suspension was resuspended by blowing and transferred into a 60mm culture dish. Digested at 37℃ for different times (15, 30, 45, 60min). After the timer was over, 3mL DMEM complete medium containing 10% FBS was added to stop the digestion. The tissue liquid was transferred into a 15mL centrifuge tube, centrifuged at 1000rpm for 3min, and the supernatant was removed. The remaining tissue precipitate was added with 5mL Hanks solution, centrifuged at 500rpm for 3min, and this step was repeated for a total of three times. Add 1 mL of DMEM complete medium (hereinafter referred to as primary cell culture medium) containing 10% FBS, 1% ITS, and 1% P / S, and resuspend the cells by blowing. Add the suspension dropwise to a 100-mesh cell sieve, gently grind 5 times with the stopper of a 5 mL syringe, rinse with 1 mL of primary cell complete culture medium, and gently grind again. Collect the filtrate and add it dropwise to a 200-mesh cell sieve, and repeat the grinding operation. Collect the sieved cell suspension and inoculate it into a T25 bottle at a ratio of one T25 culture bottle for every 4 kidneys. After inoculation for 24-36 hours, replace with fresh primary cell culture medium, and pass or intervene after about 48 hours. Digest the primary cells in good condition into a cell suspension and count the cells. Inoculate in a 6-well plate at a density of 4×105 cells / well, inoculate in a 12-well plate at a density of 105 cells / well, and inoculate in a 96-well plate at a density of 104 cells / well, and add primary cell culture medium for culture. When the fusion rate reached 70%-80%, 10% blank serum, 10% blank serum + 150mM D-gal, 5% drug-containing serum + D-gal, 10% drug-containing serum + D-gal, and 15% drug-containing serum + D-gal were added respectively for 24 hours.

[0099] 2.2.3 Cell activity detection

[0100] After 24 hours of intervention in the above 96-well plate, the old culture medium was aspirated and a 10% concentration of CCK-8 working solution was prepared using the corresponding culture medium. 100 μL of the working solution was added to each well and placed in the incubator for incubation. The absorbance of each well was detected at 450 nm using a multifunctional microplate reader every 15 minutes until the absorbance of the blank control group was about 1.

[0101] 2.2.4 SA-β-gal staining

[0102] After 24 hours of intervention, the 12-well plate was washed once with PBS, 500 μL of staining fixative was added to each well, fixed at room temperature for 20 minutes, and PBS was added to shake at 60 rpm for 5 minutes × 3 times. The staining working solution was prepared according to the ratio of A: B: C: X = 1: 1: 93: 5. 500 μL of staining working solution was added to each well, and an appropriate amount of PBS was dripped into the gap between the wells to moisturize, the plate was sealed with sealing film, and aluminum foil was wrapped to avoid light and placed in a 37°C incubator overnight. The working solution was discarded and replaced with PBS the next day, and observed and photographed using an optical microscope.

[0103] 2.2.5 Protein expression in primary renal tubular epithelial cells

[0104] Western blot was used to detect the expression of aging-related proteins P21, P16, LaminB1, and γH2Ax; the expression of fibrosis-related proteins COLⅠ and α-SMA; the expression of KAT7 and inflammasome-related proteins NLRP3 and IL-1β.

[0105] The specific operation of Western blot for primary renal tubular epithelial cells is as follows: discard the old culture medium in the 6-well plate, wash twice with PBS, add 150 μL of mixed protein lysis buffer (RIPA: protease inhibitor mixture = 100: 1), place on ice and lyse with a shaker at 60 rpm for 15 min, scrape the cells with a cell scraper, and gently blow with a pipette, transfer to a 1.5 mL EP tube for a short vortex, ultrasonicate at 50% power for 8 s + cool on ice for 8 s, repeat 5 times. Centrifuge at 12000 rpm, 4 ° C, 15 min, draw 5 μL of supernatant for protein concentration determination, add 1 / 4 volume of protein loading buffer to the remaining supernatant, vortex mix, denature at 99 ° C for 10 min in a metal bath, cool and package, and store at -80 ° C for use.

[0106] Use the gel making kit to prepare the gel of appropriate concentration, load the sample according to the protein concentration determination result, perform electrophoresis at a constant voltage of 160V, use the fast transfer solution to transfer the membrane at a current of 400mA, and transfer the membrane for 10-50min depending on the molecular weight of the target protein. Block with the fast blocking solution for 15min, wash with TBST for 3min×3 times, and incubate the membrane in the corresponding primary antibody at 4℃ overnight. The next day, take out the membrane and wash it with TBST for 5min×2 times + 10min×2 times. Put the membrane in the corresponding species secondary antibody, incubate at room temperature for 1 hour, wash with TBST for 5min×2 times + 10min×2 times, and add ECL chemical developer for exposure. Each experiment was repeated 3 times independently, and grayscale values ​​were calculated using Image J, and statistics and graphs were made using Graph Pad Prism.

[0107] 2.2.6 Data Analysis

[0108] Image J was used to detect protein grayscale values ​​and process images. Image pro plus was used to count pathological staining. Prism GraphPad 8.0 was used to analyze statistical data and make quantitative graphs. ANOVA one-way analysis of variance was used to express differences between groups, LSD method was used to express differences between two groups, and It represents quantitative data, and P < 0.05 indicates that the difference is statistically significant.

[0109] 3. Experimental results

[0110] 3.1 Chinese herbal medicine combination improves renal aging and fibrosis in naturally aged mice in vivo

[0111] like Figure 1 and Figure 2 The experimental results showed that HE staining showed that the morphology of renal tubules and glomeruli in the kidneys of 4-month-old mice was intact; at 18 months of age, mice showed pathological changes such as inflammatory cell infiltration, tubular epithelial cavitation, and glomerular atrophy, which were significantly alleviated after intervention with different doses of the Chinese herbal compound composition.

[0112] Renal function tests showed that serum creatinine, uric acid, urea nitrogen and urine protein levels increased significantly at 18 months of age, and decreased to varying degrees after intervention with the Chinese herbal compound.

[0113] Masson staining showed that collagen deposition was obvious in the kidneys of 18-month-old mice, and the Chinese medicine compound group showed significant improvement. Sirius red staining polarized light observation showed that some type III collagen and a small amount of type I collagen were present in the kidneys of young mice, and a large amount of type I and III collagen were deposited in the kidneys of 18-month-old mice, and type IV collagen also increased. The Chinese medicine compound had a significant down-regulating effect on type I collagen. Western blot showed that the levels of COLⅠ and α-SMA in the kidneys of young mice were low, and the levels were significantly increased in 18-month-old mice. The expression levels were downregulated after the intervention of the Chinese medicine compound. The differences in protein expression were statistically significant (P < 0.05, P < 0.01).

[0114] Renal SA-β-gal showed that a large amount of blue positive staining appeared in the kidneys of 18-month-old mice. After intervention with the Chinese herbal compound composition, the positive area of ​​aging staining was significantly reduced. Western blot showed that the level of LaminB1 in the kidneys of the young group was higher, while the levels of P21, P16, and γH2Ax were lower. Lamin B1 decreased significantly in 18-month-old mice, while P21, P16, and γH2Ax. After intervention with the Chinese herbal compound composition, the expression of the above aging marker proteins decreased, and the difference was statistically significant (P < 0.05, P < 0.01).

[0115] At the same time, Western blot results showed that the expression of KAT7, NLRP3, and IL-1β increased in the 18-month-old group, and the expression levels of the above proteins decreased after intervention with the Chinese medicine compound composition, and the difference was statistically significant (P < 0.05).

[0116] Immunofluorescence showed that in the kidneys of 18-month-old naturally aged mice, the green fluorescence representing KAT7 expression and the red fluorescence representing lamin B1 showed an opposite trend. It was also observed that Chinese medicine intervention reduced KAT7 while increasing the expression of renal Lamin B1.

[0117] 3.2 The serum containing the Chinese herbal medicine compound improves the senescence and fibrosis of primary renal tubular epithelial cells in vitro

[0118] like Figure 3 The experimental results showed that the cell activity test results showed that compared with the model group with blank serum and D-gal, the addition of drug-containing serum can improve the mPTCs cell activity to varying degrees, among which 10% drug-containing serum has the most obvious improvement, and the effect of 15% concentration is lower than that of 10%.

[0119] The results of SA-β-gal detection showed that the blue-green positive staining of mPTCs cells cultured with blank serum increased after D-gal intervention, while the positive staining decreased to varying degrees after intervention with different concentrations of drug-containing serum, with the 5% and 10% decreases being more obvious.

[0120] Western blot results showed that the intervention of the Chinese medicine compound serum could up-regulate the expression level of Lamin B1 protein in D-gal-induced senescent mPTCs, and down-regulate the levels of P21, P16, and γH2Ax. It was also observed that the expression levels of COLⅠ and α-SMA were down-regulated, and the differences between the groups in these changes were statistically significant (P<0.05 or P<0.01).

[0121] The phenomenon of inflammasome regulation was similar to that in vivo. Western blot results showed that the expression of KAT7, NLRP3, and IL-1β decreased after intervention with compound drug-containing serum. The in vivo and in vitro experimental results in this section suggest that the Chinese herbal compound can inhibit the activation of inflammasomes, thereby improving kidney function and fibrosis in aging.

[0122] The above implementation modes are only for illustrating the technical concept and features of the present invention, and their purpose is to enable people familiar with this technology to understand the content of the present invention and implement it, and they cannot be used to limit the protection scope of the present invention. Any equivalent changes or modifications made according to the spirit of the present invention should be included in the protection scope of the present invention.

Claims

1. A Chinese medicinal compound composition having the effect of delaying renal fibrosis, characterized in that: The invention is prepared from an extract prepared from 240-480g of astragalus, 240-480g of hibiscus flower, 240-480g of centella asiatica, 120-240g of salvia miltiorrhiza and 40-80g of liquorice and cordyceps mycelium; the weight ratio of the extract to the cordyceps mycelium is 1:0.88-1; The extract is prepared by the following method: Take astragalus, hibiscus flower, Centella asiatica, salvia miltiorrhiza and liquorice, add water to immerse the medicinal materials, soak first, decoct and extract, use gauze to squeeze the residue to collect the decoction, add water to the residue and decoct again, collect the two decoctions, filter with gauze, rotary evaporate and concentrate the filtrate, pre-freeze and use a vacuum freeze dryer to obtain freeze-dried powder.

2. The Chinese medicinal compound composition having the effect of delaying renal fibrosis according to claim 1, characterized in that: The invention is prepared from extracts made from 240g of astragalus, 240g of hibiscus flower, 240g of centella asiatica, 120g of salvia miltiorrhiza and 40g of liquorice and cordyceps mycelium.

3. The Chinese medicinal compound composition having the effect of delaying renal fibrosis according to claim 1, characterized in that: The extract is prepared by the following method: Take Astragalus, Hibiscus flower, Centella asiatica, Salvia miltiorrhiza and Licorice, add 5-15 times the volume of water by weight of the medicinal materials to immerse the medicinal materials, soak for 30-40 minutes, decoct and extract for 30-60 minutes, squeeze the residue with gauze to collect the decoction, add 5-15 times the volume of water to the residue again and decoct for 30-60 minutes, collect the decoctions twice, filter with gauze, concentrate the filtrate by rotary evaporation, pre-freeze at -80°C for 24 hours, and then use a vacuum freeze dryer for 72 hours to obtain a freeze-dried powder.

4. A Chinese medicine preparation having the effect of delaying renal fibrosis, characterized in that: The Chinese medicine compound composition according to any one of claims 1 to 3 and a pharmaceutically acceptable carrier are prepared into granules, tablets, capsules, pills, powders, mixtures, and pastes.

5. Use of the Chinese medicine compound composition according to any one of claims 1 to 3 in the preparation of a medicament for treating renal fibrosis.